Pericyte phenotype switching in cancer
Trends in Cancer · 2025-09 · 11 (9) · 877-888
DOI: 10.1016/j.trecan.2025.06.005 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Trends in Cancer, 2025-09. Verfasst von Bo He und 1 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Microenvironment Laboratory, Harry Perkins Institute of Medical Research, QEII Medical Centre and Centre for Medical Research, The University …. Hauptthemen laut MEDLINE: Pericytes, Neoplasms, Neovascularization, Pathologic. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 86 Literaturangaben. Gefördert von: Cancer Australia, Cancer Council Western Australia, Eisai Canada.
Abstract (Originalsprache)
Pericytes play an important physiological role as guardians of vascular integrity. In cancer, however, pericytes undergo profound phenotypic changes which foster tumor progression. Emerging transcriptomics and functional data provide evidence for a shift from quiescent to highly proliferating, matrix-secreting pericytes which destabilize the vasculature and create immune deserts. However, due to their inherent plasticity, proliferative tumor pericytes can be 'coerced' to switch back into a more quiescent and contractile state, a process which underpins durable tumor vessel normalization. Therapeutically, pericyte phenotype switching can be induced by targeting oncogenic, metabolic, or microtubule signaling pathways which induce Rho kinase activity. Thus, harnessing pericyte plasticity provides unique opportunities to synergize targeted anticancer therapies with immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cancer Microenvironment Laboratory, Harry Perkins Institute of Medical Research, QEII Medical Centre and Centre for Medical Research, The University of Western Australia, Perth, Australia.
- Cancer Microenvironment Laboratory, Harry Perkins Institute of Medical Research, QEII Medical Centre and Centre for Medical Research, The University of Western Australia, Perth, Australia. Electronic address: ganss@perk…
Förderung
- Cancer Australia
- Cancer Council Western Australia
- Eisai Canada
- National Health and Medical Research Council
- Worldwide Cancer Research
Zitieren
APA
He, B., & Ganss, R. (2025). Pericyte phenotype switching in cancer. Trends in Cancer, 11(9), 877-888. https://doi.org/10.1016/j.trecan.2025.06.005
Vancouver
He B, Ganss R. Pericyte phenotype switching in cancer. Trends in Cancer. 2025;11(9):877-888. doi:10.1016/j.trecan.2025.06.005
BibTeX
@article{He2025,
author = {He, Bo and Ganss, Ruth},
title = {Pericyte phenotype switching in cancer},
journal = {Trends in Cancer},
year = {2025},
volume = {11},
number = {9},
pages = {877--888},
doi = {10.1016/j.trecan.2025.06.005}
}
EUVIMED